SCHEMBL1747233

SCHEMBL1747233

CC(C)[C@@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc(-c3ccc(-c4c[nH]c([C@@H]5CCCN5C(=O)CNC5CCOCC5)n4)cc3)cc2)c[nH]1)N(C)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.38
CYP2C9 P11712 5/20 0.36
KCNH2 Q12809 2/20 0.35
NR1I2 O75469 2/20 0.35
ABCB11 O95342 1/20 0.35
OPRK1 P41145 1/20 0.35
TLR9 Q9NR96 2/20 0.35
TLR8 Q9NR97 2/20 0.35
TLR7 Q9NYK1 2/20 0.35
CYP1A2 P05177 3/20 0.34
PRCP P42785 3/20 0.33
CYP2D6 P10635 2/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1747170 0.91 CYP3A4 (0.38) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL1745662 0.91 CYP3A4 (0.38) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL1747298 0.89 CYP3A4 (0.43) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL1745953 0.89 CYP3A4 (0.43) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL4982182 0.87 CYP3A4 (0.46) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL1980307 0.82 CYP3A4 (0.40) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL1982625 0.82 CYP3A4 (0.39) CYP3A4CYP2C9KCNH2NR1I2ABCB11
Hydrochloric Acid SCHEMBL1440458 0.81 CYP3A4 (0.39) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL15105941 0.81 CYP3A4 (0.40) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL1747368 0.78 CYP3A4 (0.56) CYP3A4CYP2C9KCNH2NR1I2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049522-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-05-14 EP claimed
EP-2385048-A1 Hepatitis C virus inhibitors Bristol-Myers Squibb Company (US) 2011-11-09 EP disclosed
US-20110252687-A1 Canting Vertical Fore Grip with Bipod GRIP POD SYSTEMS, LLC 2011-10-20 US disclosed